DOI:
10.1055/s-00000005
Aktuelle Rheumatologie
LinksClose Window
References
Distler O. et al.
Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease.
N Engl J Med 2019;
380: 2518-2528 doi:10.1056/NEJMoa1903076.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.